Ospedale Di Sassuolo S.p.A. — Clinical Trial Site

11 Registered trials

6 Currently recruiting

Organisation

Ospedale Di Sassuolo S.p.A.

Location

Sassuolo, Italy

Identifier

ORG-100047351

Address

Via Francesco Ruini 2, 41049, Italy

Departments

DAY HOSPITAL ONCOLOGICO
Day Hospital Oncologico - Ospedale di Sassuolo
Day Hospital Oncologico -Ospedale di Sassuolo
Discipline chirurgiche
Medical oncology
Ostetricia e Ginecologia
U.O.S.D. di Oncologia
UOSD Oncologia

Clinical trials at this site (11)

Search interface

PeRinatal Outcomes with ACTive versus expectant management of women with Pre-labor Rupture Of Membranes: a phase III, open-label, randomized… Recruiting

2024-517504-11-00 Pregnant patients diagnosed with premature rupture of m 5 2025-01-29
MITO 31- A phase II trial of Olaparib in patients with recurrent ovarian cancer wild type for germline and somatic BRCA 1 and 2 genes: The M… Recruiting

2024-516841-38-00 recurrent ovarian cancer wild type for germline and som 4 2025-01-09
MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, … Recruiting

2024-516839-27-00 BRCA wild-type advanced ovarian, fallopian tube and pri 4 2024-12-09
Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFI… Recruiting

2024-517863-22-00 Study population consists in patients with a diagnosis 5 2024-12-01
Phase III trial comparing local radiotherapy alone or with Obinutuzumab in early stage Follicular Lymphoma: the GAZEBO Trial. Recruiting

2022-502775-29-01 Early stage Follicular Lymphoma 5 2023-12-14
A study to assess efficacy of citicoline on visual field preservation in patients with glaucoma Recruiting

2022-502273-42-00 Glaucoma 5 2023-11-08
Shortened vs standard chemotherapy combined with immunotherapy for the initial treatment of patients with high tumor burden Follicular Lymph… Ended

2024-511636-27-00 Follicular Lymphoma 5 2021-12-01
Prephase treatment with prednisone +/- Vitamin D supplementation followed by immunochemotherapy in Elderly patients with Diffuse Large B-Cel… Ended

2024-511637-35-00 Elderly patients with Diffuse Large B-Cell Lymphoma (DL 5 2021-03-23
A study to determine whether the addition of Dostarlimab (TSR-042) delays recurrence of advanced endometrial cancer Ended

2023-506551-23-00 Recurrent or primary advanced (Stage III or IV) endomet 5 2019-11-21
Sustained treatment-free period in the course of a disease when symptoms become less severe in BCR-ABL+ chronic myeloid leukemia: a prospect… Ended

2023-510434-83-00 Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) 6 2016-10-17
A randomized phase III multicenter trial assessing efficacy and toxicity of a combination of Rituximab and Lenalidomide (R2) vs Rituximab al… Ended

2024-511640-11-00 Follicular lymphoma 5 2014-05-15